Advertisement
Canada markets closed
  • S&P/TSX

    21,947.41
    +124.19 (+0.57%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CAD/USD

    0.7308
    -0.0006 (-0.08%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • Bitcoin CAD

    86,365.44
    +5,387.25 (+6.65%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • RUSSELL 2000

    2,035.72
    +19.61 (+0.97%)
     
  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     
  • NASDAQ

    16,156.33
    +315.37 (+1.99%)
     
  • VOLATILITY

    13.49
    -1.19 (-8.11%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • CAD/EUR

    0.6787
    -0.0030 (-0.44%)
     

Plexus (PLXS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Plexus (PLXS) reported $966.9 million in revenue for the quarter ended March 2024, representing a year-over-year decline of 9.7%. EPS of $0.94 for the same period compares to $1.45 a year ago.

The reported revenue represents a surprise of +1.64% over the Zacks Consensus Estimate of $951.35 million. With the consensus EPS estimate being $0.87, the EPS surprise was +8.05%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Market Sector- Healthcare/Life Sciences: $379 million compared to the $361.74 million average estimate based on two analysts. The reported number represents a change of -22.3% year over year.

  • Revenue- Market Sector- Aerospace/Defense: $170 million compared to the $162.24 million average estimate based on two analysts. The reported number represents a change of +18.1% year over year.

  • Revenue- Market Sector- Industrial: $418 million versus $426.44 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -4.8% change.

View all Key Company Metrics for Plexus here>>>

Shares of Plexus have returned +6.2% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Plexus Corp. (PLXS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research